The GABAA receptor is an FMRP target with therapeutic potential in fragile X syndrome.
Détails
ID Serval
serval:BIB_22998BD1D4EB
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
The GABAA receptor is an FMRP target with therapeutic potential in fragile X syndrome.
Périodique
Cell cycle (Georgetown, Tex.)
ISSN
1551-4005 (Electronic)
ISSN-L
1551-4005
Statut éditorial
Publié
Date de publication
2015
Volume
14
Numéro
18
Pages
2985-2995
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Publication Status: ppublish
Résumé
Previous research indicates that the GABAAergic system is involved in the pathophysiology of the fragile X syndrome, a frequent form of inherited intellectual disability and associated with autism spectrum disorder. However, the molecular mechanism underlying GABAAergic deficits has remained largely unknown. Here, we demonstrate reduced mRNA expression of GABAA receptor subunits in the cortex and cerebellum of young Fmr1 knockout mice. In addition, we show that the previously reported underexpression of specific subunits of the GABAA receptor can be corrected in YAC transgenic rescue mice, containing the full-length human FMR1 gene in an Fmr1 knockout background. Moreover, we demonstrate that FMRP directly binds several GABAA receptor mRNAs. Finally, positive allosteric modulation of GABAA receptors with the neurosteroid ganaxolone can modulate specific behaviors in Fmr1 knockout mice, emphasizing the therapeutic potential of the receptor.
Mots-clé
Animals, Fragile X Mental Retardation Protein/genetics, Fragile X Mental Retardation Protein/metabolism, Fragile X Mental Retardation Protein/physiology, Fragile X Syndrome/therapy, GABA-A Receptor Antagonists/pharmacology, Genotype, Humans, Male, Mice, Mice, Knockout, Mice, Transgenic, Pregnanolone/analogs & derivatives, Pregnanolone/pharmacology, RNA, Messenger/metabolism, Receptors, GABA-A/genetics, Receptors, GABA-A/metabolism
Pubmed
Open Access
Oui
Création de la notice
06/03/2017 17:23
Dernière modification de la notice
20/08/2019 13:00